Sen Utpal, Tyagi Neetu, Patibandla Phani K, Dean William L, Tyagi Suresh C, Roberts Andrew M, Lominadze David
Dept. of Physiology, Univ. of Louisville, School of Medicine, Bldg. A, Rm. 1115, 500 South Preston St., Louisville, KY 40202, USA.
Am J Physiol Cell Physiol. 2009 Apr;296(4):C840-7. doi: 10.1152/ajpcell.00515.2008. Epub 2009 Feb 4.
We previously demonstrated that fibrinogen (Fg) binding to the vascular endothelial intercellular adhesion molecule-1 (ICAM-1) leads to microvascular constriction in vivo and in vitro. Although a role of endothelin-1 (ET-1) in this Fg-induced vasoconstriction was suggested, the mechanism of action was not clear. In the current study, we tested the hypothesis that Fg-induced vasoconstriction results from ET-1 production by vascular endothelial cells (EC) and is mediated by activation of extracellular signal-regulated kinase -1/2 (ERK-1/2). Confluent, rat heart microvascular endothelial cells (RHMECs) were treated with one of the following: Fg (2 or 4 mg/ml), Fg (4 mg/ml) with ERK-1/2 kinase inhibitors (PD-98059 or U-0126), Fg (4 mg/ml) with an antibody against ICAM-1, or medium alone for 45 min. The amount of ET-1 formed and the concentration of released von Willebrand factor (vWF) in the cell culture medium were measured by ELISAs. Fg-induced exocytosis of Weibel-Palade bodies (WPBs) was assessed by immunocytochemistry. Phosphorylation of ERK-1/2 was detected by Western blot analysis. Fg caused a dose-dependent increase in ET-1 formation and release of vWF from the RHMECs. This Fg-induced increase in ET-1 production was inhibited by specific ERK-1/2 kinase inhibitors and by anti-ICAM-1 antibody. Immunocytochemical staining showed that an increase in Fg concentration enhanced exocytosis of WPBs in ECs. A specific endothelin type B receptor blocker, BQ-788, attenuated the enhanced phosphorylation of ERK-1/2 in ECs caused by increased Fg content in the culture medium. The presence of an endothelin converting enzyme inhibitor, SM-19712, slightly decreased Fg-induced phosphorylation of ERK-1/2, but inhibited production of Fg-induced ET-1 production. These results suggest that Fg-induced vasoconstriction may be mediated, in part, by activation of ERK-1/2 signaling and increased production of ET-1 that further increases EC ERK-1/2 signaling. Thus, an increased content of Fg may enhance vasoconstriction through increased production of ET-1.
我们之前证实,纤维蛋白原(Fg)与血管内皮细胞间黏附分子-1(ICAM-1)结合会在体内和体外导致微血管收缩。尽管有研究提示内皮素-1(ET-1)在这种Fg诱导的血管收缩中发挥作用,但其作用机制尚不清楚。在本研究中,我们验证了以下假设:Fg诱导的血管收缩是由血管内皮细胞(EC)产生ET-1所致,并由细胞外信号调节激酶-1/2(ERK-1/2)的激活介导。将汇合的大鼠心脏微血管内皮细胞(RHMECs)进行如下处理:Fg(2或4mg/ml)、Fg(4mg/ml)与ERK-1/2激酶抑制剂(PD-98059或U-0126)、Fg(4mg/ml)与抗ICAM-1抗体,或仅用培养基处理45分钟。通过酶联免疫吸附测定(ELISA)测量细胞培养基中形成的ET-1量和释放的血管性血友病因子(vWF)浓度。通过免疫细胞化学评估Fg诱导的魏尔-帕拉德小体(WPB)胞吐作用。通过蛋白质印迹分析检测ERK-1/2的磷酸化。Fg导致ET-1形成以及RHMECs释放vWF呈剂量依赖性增加。这种Fg诱导的ET-1产生增加受到特异性ERK-1/2激酶抑制剂和抗ICAM-1抗体的抑制。免疫细胞化学染色显示,Fg浓度增加会增强ECs中WPB的胞吐作用。一种特异性内皮素B型受体阻滞剂BQ-788减弱了培养基中Fg含量增加所导致的ECs中ERK-1/2增强的磷酸化。内皮素转换酶抑制剂SM-19712的存在略微降低了Fg诱导的ERK-1/2磷酸化,但抑制了Fg诱导的ET-1产生。这些结果表明,Fg诱导的血管收缩可能部分由ERK-1/2信号激活和ET-1产生增加介导,而ET-1产生增加会进一步增强EC ERK-1/2信号。因此,Fg含量增加可能通过增加ET-1产生来增强血管收缩。